| * Adobe Inc ADBE.O: Stifel cuts target price to $450 from $480 |
| * Air Products APD.N: Jefferies cuts target price to $300 from $350 |
| * Alexander & Baldwin Inc (Hawaii) ALEX.N: Piper Sandler cuts to neutral from overweight |
| * Align Technology ALGN.O: Barclays initiates coverage with equal-weight rating |
| * Align Technology ALGN.O: Barclays initiates coverage with target price $170 |
| * American Airlines AAL.O: BMO initiates coverage with market perform rating |
| * American Airlines AAL.O: BMO initiates coverage with target price $16.75 |
| * Amneal Pharmaceuticals AMRX.O: Barclays initiates coverage with target price $15 |
| * Amneal Pharmaceuticals AMRX.O: Barclays initiates coverage with overweight rating |
| * Amphastar Pharmaceuticals Inc AMPH.O: Barclays initiates coverage with equal weight rating |
| * Amphastar Pharmaceuticals Inc AMPH.O: Barclays initiates coverage with target price $30 |
| * Ani Pharmaceuticals Inc ANIP.O: Barclays initiates coverage with overweight rating |
| * Ani Pharmaceuticals Inc ANIP.O: Barclays initiates coverage with target price $100 |
| * Antero Resources Corp AR.N: BMO raises target price to $40 from $37 |
| * Antero Resources Corp AR.N: JP Morgan raises target price to $42 from $39 |
| * Antero Resources Corp AR.N: Morgan Stanley raises target price to $48.00 from $44.00 |
| * Apple Inc AAPL.O: Citigroup raises target price to $330 from $315 |
| * Arrowhead Pharmaceuticals ARWR.O: BofA Global Research raises price objective to $81 from $62 |
| * AstraZeneca AZN.O: TD Cowen raises target price to $105 from $95 |
| * BorgWarner Inc. BWA.N: Wells Fargo cuts target price to $52 from $54 |
| * Brightspring Health Services Inc BTSG.O: BofA Global Research raises price objective to $41 from $38 |
| * Broadcom Inc AVGO.O: Rosenblatt Securities raises target price to $440 from $400 |
| * California Resources Corporation CRC.N: Wells Fargo cuts target price to $56 from $58 |
| * Cardinal Health CAH.N: Barclays initiates coverage with overweight rating and PT $243 |
| * Cencora COR.N: Barclays initiates coverage with overweight rating and PT $400 |
| * Ceribell Inc CBLL.O: TD Cowen raises target price to $29 from $20 |
| * Chimera Investment Corp CIM.N: RBC cuts to sector perform from outperform |
| * Chimera Investment Corp CIM.N: RBC raises target price to $13 from $6 |
| * Ciena Corp CIEN.N: Stifel raises target price to $230 from $152 |
| * Colgate-Palmolive Co CL.N: RBC raises to outperform from sector perform |
| * Collegium Pharmaceutical Inc. COLL.O: Barclays initiates coverage with overweight rating |
| * Collegium Pharmaceutical Inc. COLL.O: Barclays initiates coverage with target price $58 |
| * Confluent CFLT.O: Deutsche Bank cuts to hold from buy |
| * Confluent CFLT.O: Deutsche Bank raises target price to $31 from $29 |
| * Confluent Inc CFLT.O: Canaccord Genuity cuts to hold from buy; ups PT to $31 from $27 |
| * Confluent Inc CFLT.O: D.A. Davidson cuts to neutral from buy; raises PT to $31 from $29 |
| * Confluent Inc CFLT.O: Deutsche Bank cuts to hold from buy; raises PT to $31 from $29 |
| * Confluent Inc CFLT.O: Mizuho cuts to neutral from outperform; ups PT to $31 from $26 |
| * Confluent Inc CFLT.O: Needham cuts to hold from buy |
| * Confluent Inc CFLT.O: Oppenheimer cuts to perform from outperform |
| * Confluent Inc CFLT.O: Raymond James cuts to market perform from outperform |
| * Confluent Inc CFLT.O: RBC cuts to sector perform from outperform |
| * Confluent Inc CFLT.O: RBC raises target price to $31 from $30 |
| * Confluent Inc CFLT.O: Stephens cuts to equal-weight from overweight |
| * Confluent Inc CFLT.O: Stephens raises target price to $31 from $29 |
| * Confluent Inc CFLT.O: TD Cowen raises target price to $31 from $27 |
| * Confluent Inc CFLT.O: Truist Securities cuts to hold from buy; ups PT to $31 from $29 |
| * Confluent Inc CFLT.O: UBS cuts to neutral from buy |
| * Confluent Inc CFLT.O: UBS raises target price to $31 from $29 |
| * Confluent Inc CFLT.O: Wells Fargo cuts to equal weight from overweight |
| * Confluent Inc CFLT.O: Wells Fargo raises target price to $31 from $30 |
| * Cross Country Healthcare Inc CCRN.O: UBS cuts target price to $9 from $16.5 |
| * Cullinan Therapeutics Inc CGEM.O: Wedbush raises target price to $34 from $25 |
| * Dana Incorporated DAN.N: Wells Fargo raises target price to $23 from $21 |
| * Deere & Co DE.N: Jefferies raises target price to $475 from $440 |
| * Definitive Healthcare Corp DH.O: Barclays cuts target price to $2.75 from $3 |
| * Delta Air Lines Inc DAL.N: BMO initiates coverage with outperform rating; PT $80 |
| * Dentsply Sirona XRAY.O: Barclays initiates coverage with underweight rating and PT $12 |
| * Dollar Tree Inc DLTR.O: Barclays raises target price to $136 from $120 |
| * Doximity DOCS.N: Barclays initiates coverage with overweight rating and PT $63 |
| * Dyne Therapeutics Inc DYN.O: Bernstein raises target price to $23 from $21 |
| * Dyne Therapeutics Inc DYN.O: Morgan Stanley raises target price to $50.00 from $46.00 |
| * Elanco Animal Health Inc. ELAN.N: Barclays initiates coverage with overweight rating |
| * Elanco Animal Health Inc. ELAN.N: Barclays initiates coverage with target price $30 |
| * Envista Holdings Corp. NVST.N: Barclays initiates coverage with overweight rating |
| * Envista Holdings Corp. NVST.N: Barclays initiates coverage with target price $24 |
| * FMC Corp. FMC.N: Barclays cuts target price to $13 from $16 |
| * FMC Corp. FMC.N: Barclays cuts to underweight from equal-weight |
| * Galaxy Digital Inc GLXY.O: Citizens initiates coverage with market outperform rating |
| * Galaxy Digital Inc GLXY.O: Citizens initiates coverage with target price $60 |
| * General Motors Co. GM.N: Wells Fargo raises target price to $48 from $46 |
| * Glaukos Corp GKOS.N: Needham raises target price to $125 from $117 |
| * Goodrx Holdings Inc. GDRX.O: Barclays initiates coverage with target price $3 |
| * Goodrx Holdings Inc. GDRX.O: Barclays initiates coverage with underweight rating |
| * Graphic Packaging Holding Co GPK.N: Baird cuts target price to $18 from $24 |
| * Healthequity HQY.O: Barclays initiates coverage with overweight rating and PT $118 |
| * Henry Schein HSIC.O: Barclays initiates coverage with overweight rating and PT $86 |
| * Hims & Hers Health HIMS.N: Barclays initiates coverage with overweight rating |
| * Hims & Hers Health HIMS.N: Barclays initiates coverage with target price $48 |
| * Hormel Foods Corp. HRL.N: Barclays cuts target price to $30 from $31 |
| * IBM IBM.N: Stifel raises target price to $325 from $295 |
| * Idexx Laboratories, Inc. IDXX.O: Barclays initiates coverage with overweight rating |
| * Idexx Laboratories, Inc. IDXX.O: Barclays initiates coverage with target price $850 |
| * Immix Biopharma, Inc. IMMX.O: H.C. Wainwright raises target price to $12 from $8 |
| * Ionis Pharmaceuticals IONS.O: BofA Global Research ups price objective to $97 from $86 |
| * Jack In the Box Inc JACK.O: RBC raises target price to $25 from $16 |
| * Keycorp KEY.N: Piper Sandler raises target price to $22 from $20 |
| * Kroger Co KR.N: Citigroup cuts target price to $68 from $74 |
| * Kymera Therapeutics KYMR.O: Barclays raises target price to $119 from $70 |
| * Kymera Therapeutics KYMR.O: Oppenheimer raises target price to $120 from $67 |
| * Kymera Therapeutics Inc KYMR.O: BofA Global Research ups price objective to $112 from $71 |
| * Kymera Therapeutics Inc KYMR.O: BTIG raises target price to $138 from $75 |
| * Kymera Therapeutics Inc KYMR.O: H.C. Wainwright raises target price to $134 from $84 |
| * Kymera Therapeutics Inc KYMR.O: Morgan Stanley raises target price to $127.00 from $73.00 |
| * Kymera Therapeutics Inc KYMR.O: Piper Sandler raises target price to $125 from $98 |
| * Kymera Therapeutics Inc KYMR.O: Truist Securities raises target price to $116 from $80 |
| * Kymera Therapeutics Inc KYMR.O: Wells Fargo raises target price to $116 from $69 |
| * Lear Corporation LEA.N: Wells Fargo cuts target price to $107 from $112 |
| * Lifestance Health Group Inc LFST.O: Barclays initiates coverage with overweight rating |
| * Lifestance Health Group Inc LFST.O: Barclays initiates coverage with target price $8 |
| * Ligand Pharmaceuticals Inc LGND.O: Citigroup initiates coverage with buy rating |
| * Ligand Pharmaceuticals Inc LGND.O: Citigroup initiates coverage with price target $270 |
| * Lyell Immunopharma Inc LYEL.O: H.C. Wainwright raises target price to $45 from $20 |
| * Lyell Immunopharma Inc LYEL.O: H.C. Wainwright raises to buy from neutral |
| * Lyft, Inc. LYFT.O: Wells Fargo raises target price to $26 from $20 |
| * Mannkind Corp MNKD.O: Leerink Partners raises target price to $9 from $7 |
| * McKesson MCK.N: Barclays initiates coverage with overweight rating and PT $960 |
| * Micron Technology Inc MU.O: Bernstein raises target price to $270 from $170 |
| * Mirum Pharmaceuticals MIRM.O: Morgan Stanley raises target price to $95.00 from $81.00 |
| * Mosaic MOS.N: Barclays cuts target price to $31 from $35 |
| * Nextera Energy Inc NEE.N: BTIG raises target price to $100 from $98 |
| * Nike Inc NKE.N: Citigroup cuts target price to $70 from $74 |
| * NRG Energy Inc NRG.N: UBS initiates coverage with buy rating and target price $211 |
| * Nurix Therapeutics Inc NRIX.O: BTIG raises target price to $30 from $27 |
| * Omnicell Inc OMCL.O: Benchmark raises target price to $50 from $45 |
| * Option Care Health OPCH.O: Deutsche Bank raises target price to $36 from $31 |
| * Option Care Health Inc OPCH.O: BofA Global Research ups price objective to $35 from $32 |
| * Oracle Corp. ORCL.N: Barclays cuts target price to $330 from $400 |
| * Organon OGN.N: Barclays initiates coverage with underweight rating and PT $7.5 |
| * Otis Worldwide Corp OTIS.N: Exane BNP Paribas raises to outperform from neutral |
| * Pacira Biosciences PCRX.O: Barclays initiates coverage with equal-weight rating |
| * Pacira Biosciences PCRX.O: Barclays initiates coverage with target price $27 |
| * Paramount Skydance Corporation PSKY.O: Morgan Stanley raises target to $12.00 from $10.00 |
| * Paychex Inc PAYX.O: BMO cuts target price to $121 from $140 |
| * Paychex, Inc. PAYX.O: Wells Fargo cuts target price to $116 from $128 |
| * PayPal Holdings, Inc. PYPL.O: Wells Fargo cuts target price to $67 from $74 |
| * Penske Automotive Group PAG.N: BofA Global Research reinstates with buy rating |
| * Penske Automotive Group PAG.N: BofA Global Research reinstates with price objective $195 |
| * Peoples Financial Services Corp PFIS.O: Stephens cuts to equal-weight from overweight |
| * Pepsico PEP.O: Jefferies raises target price to $164 from $163 |
| * Pepsico PEP.O: Piper Sandler raises target price to $172 from $161 |
| * Phathom Pharmaceuticals Inc. PHAT.O: Barclays initiates coverage with equal-weight rating |
| * Phathom Pharmaceuticals Inc. PHAT.O: Barclays initiates coverage with target price $16 |
| * Phreesia PHR.N: Barclays initiates coverage with overweight rating and PT $26 |
| * Pilgrim'S Pride Corp PPC.O: Barclays cuts target price to $45 from $49 |
| * Planet Fitness Inc PLNT.N: RBC raises target price to $135 from $120 |
| * Progressive Corp PGR.N: BMO cuts target price to $256 from $260 |
| * Progressive Corp PGR.N: BofA Global Research cuts price objective to $348 from $350 |
| * Progyny PGNY.O: Barclays initiates coverage with overweight rating and PT $29 |
| * Pseg PEG.N: BofA Global Research adds stock to its US 1 list |
| * Rapport Therapeutics, Inc. RAPP.O: H.C. Wainwright raises target price to $40 from $34 |
| * RPM International Inc RPM.N: RBC raises target price to $132 from $121 |
| * RPM International Inc RPM.N: RBC raises to outperform from sector perform |
| * Sarepta Therapeutics Inc SRPT.O: Wedbush initiates coverage with outperform rating |
| * Sarepta Therapeutics Inc SRPT.O: Wedbush initiates coverage with target price $32 |
| * SL Green Realty Corp SLG.N: Deutsche Bank cuts target price to $46 from $60 |
| * SLM Corp SLM.O: Morgan Stanley cuts target price to $31.00 from $36.00 |
| * SLM Corp SLM.O: Morgan Stanley cuts to equal-weight from overweight |
| * Southwest Airlines Co LUV.N: BMO initiates coverage with market perform rating; PT $43 |
| * Southwest Gas Holdings Inc SWX.N: Jefferies cuts target price to $89 from $92 |
| * Structure Therapeutics Inc GPCR.O: Citigroup raises target price to $100 from $60 |
| * Synopsys Inc SNPS.O: Rosenblatt Securities cuts target price to $560 from $605 |
| * Synopsys Inc SNPS.O: Rosenblatt Securities raises to buy from neutral |
| * Talkspace TALK.O: Barclays initiates coverage with equal-weight rating and PT $3.5 |
| * Tarsus Pharmaceuticals TARS.O: Barclays initiates coverage with overweight rating |
| * Tarsus Pharmaceuticals TARS.O: Barclays initiates coverage with target price $100 |
| * Teladoc Health TDOC.N: Barclays initiates coverage with target price $8.5 |
| * Teladoc Health TDOC.N: Barclays initiates coverage with equal-weight rating |
| * Terns Pharmaceuticals TERN.O: Barclays raises target price to $56 from $36 |
| * Terns Pharmaceuticals Inc TERN.O: BMO raises target price to $54 from $35 |
| * Terns Pharmaceuticals Inc TERN.O: H.C. Wainwright raises target price to $60 from $20 |
| * Terns Pharmaceuticals Inc TERN.O: Mizuho raises target price to $54 from $33 |
| * Terns Pharmaceuticals Inc TERN.O: Oppenheimer raises target price to $58 from $28 |
| * Terns Pharmaceuticals Inc TERN.O: Oppenheimer raises target price to $58 from $28 |
| * Terns Pharmaceuticals Inc TERN.O: Truist Securities raises target price to $56 from $35 |
| * Thor Industries Inc THO.N: Truist Securities raises target price to $112 from $110 |
| * Truist Financial Corp TFC.N: Piper Sandler raises target price to $50 from $48 |
| * Tyler Technologies Inc TYL.N: D.A. Davidson cuts target price to $510 from $540 |
| * United Airlines UAL.O: BMO initiates coverage with outperform rating; target price $125 |
| * Vail Resorts MTN.N: Deutsche Bank raises target price to $162 from $159 |
| * Viatris Inc. VTRS.O: Barclays initiates coverage with overweight rating and PT $15 |
| * Visteon Corp. VC.O: Wells Fargo cuts target price to $148 from $151 |
| * Vor Biopharma Inc VOR.O: JP Morgan initiates coverage with overweight rating; PT $43 |
| * Warner Bros Discovery Inc WBD.O: Deutsche Bank raises target price to $29.50 from $26 |
| * Warner Bros Discovery Inc WBD.O: Seaport Research Partners cuts to neutral from buy |
| * Waystar Holding Corp. WAY.O: Barclays cuts target price to $42 from $50 |
| * Wells Fargo WFC.N: Piper Sandler raises target price to $100 from $93 |
| * Weyerhaeuser Co WY.N: CIBC cuts target price to $27 from $30 |
| * Wingstop Inc WING.O: RBC raises target price to $350 from $300 |
| * Wynn Resorts Ltd WYNN.O: BofA Global Research raises price objective to $150 from $140 |
| * Xeris Biopharma Holdings Inc. XERS.O: Barclays initiates coverage with overweight rating |
| * Xeris Biopharma Holdings Inc. XERS.O: Barclays initiates coverage with target price $9 |
| * Zoetis Inc. ZTS.N: Barclays initiates coverage with equal-weight rating and PT $136 |
